Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131I‐MIBG in patients with relapsed/refractory neuroblastoma

Clinical Applications and the Roles of Transporters in Disposition, Tumor Targeting, and Tissue Toxicity of meta-Iodobenzylguanidine (mIBG)

(2022) Antonio J Lopez Quiñones et al.   DRUG METABOLISM AND DISPOSITION

Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolism

(2021) Shunsuke Kimura et al.   PLoS One

Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium

(2021) Steven G. DuBois et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma

(2018) Judith G. Villablanca et al.   PEDIATRIC BLOOD & CANCER

MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling

(2018) Johanna Dzieran et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neuroblastoma is composed of two super-enhancer-associated differentiation states

(2017) Tim van Groningen et al.   NATURE GENETICS

Phase I/II study of 131I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma

(2015) S G DuBois et al.   BRITISH JOURNAL OF CANCER

Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)

(2015) Margaret J. Zhou et al.   EUROPEAN JOURNAL OF CANCER

Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults

(2011) Alexei L. Polishchuk et al.   CANCER

Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: Efficacy and underlying mechanisms

(2011) Sabine Mueller et al.   CANCER LETTERS

The MYCN oncogene and differentiation in neuroblastoma

(2011) Ulrica K. Westermark et al.   SEMINARS IN CANCER BIOLOGY